C6ORF97-ESR1 breast cancer susceptibility locus: Influence on progression and survival in breast cancer patients

European Journal of Human Genetics

Volumn 23, Issue 7, 2015, Pages 949-956

  Yamamoto Ibusuki, Mutsuko ^a   Yamamoto, Yutaka ^a   Fujiwara, Saori ^a   Sueta, Aiko ^a   Yamamoto, Satoko ^a   Hayashi, Mitsuhiro ^a   Tomiguchi, Mai ^a   Takeshita, Takashi ^a   Iwase, Hirotaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; CARRIER PROTEIN; CCDC170 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA;

ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; C6ORF GENE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; ESR1 GENE; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; BREAST TUMOR; DISEASE COURSE; DISEASE FREE SURVIVAL; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED;

ADULT; ALLELES; BREAST NEOPLASMS; CARRIER PROTEINS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84930864847     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.219     Document Type: Article

References (21)

1. Germain D. Estrogen carcinogenesis in breast cancer. Endocrin Metab Clin 2011; 40 473-484.
2. Zheng W, Long J, Gao YT et al: Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009; 41: 324-328.
3. Turnbull C, Ahmed S, Morrison J et al: Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010; 42: 504-507.
4. Sueta A, Ito H, Kawase T et al: A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat 2012; 132: 711-721.
5. Cai Q, Wen W, Qu S et al: Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res 2011; 71: 1344-1355.
6. Stacey SN, Sulem P, Zanon C et al: Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 2010; 6: e1001029.
7. Drury S, Johnson N, Salter J et al: A breast cancer-associated SNP Adjacent to ESR1 correlated with oestrogen receptor-alpha level in invasive breast tumors. PLoS Genet 2011; 7: e1001382.
8. Dunbier AK, Anderson H, Ghazoui Z et al: ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genet 2011; 7: e1001382.
9. McShane LM, Altman DG, Sauerbrei W et al: REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer (Oxford, England: 1990) 2005; 41: 1690-1696.
10. Goldhirsch A, Wood WC, Gelber RD et al: Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21: 3357-3365.
11. Goldhirsch A, Glick JH, Gelber RD et al: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16: 1569-1583.
12. Goldhirsch A, Wood WC, Gelber RD et al: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007; 18: 1133-1144.
13. Ibusuki M, Fu P, Yamamoto S et al: Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens. Breast cancer 2013; 20: 159-166.
14. Tapper W, Hammond V, Gerty S et al: The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer. Breast Cancer Res 2008; 10: R108.
15. Gyorffy B, Lanczky A, Eklund AC et al: An online survival analysis tool to rapidly assess the effect of 22, 277 genes on breast cancer prognosis using microarray data of 1, 809 patients. Breast Cancer Res Treat 2010; 123: 725-731.
16. Yang Z, Shen J, Cao Z, Wang B. Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk. Breast Cancer Res Treat 2013; 139: 267-275.
17. Zheng W, Zhang B, Cai Q et al: Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet 2013; 22: 2539-2550.
18. Mizoo T, Taira N, Nishiyama K et al: Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women. BMC Cancer 2013; 13: 565.
19. Horne HN, Sherman ME, Garcia-Closas M et al: Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression. Breast Cancer Res Treat 2014; 143: 181-187.
20. Riaz M, Berns EM, Sieuwerts AM et al: Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat 2012; 133: 843-851.
21. Fasching PA, Pharoah PD, Cox A et al: The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 2012; 21: 3926-3939.